Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0001511 (
Adhesion
)
5,955
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cooperation between integrins and growth factor receptors plays an important role in the regulation of cell growth, differentiation, and survival. The function of growth factor receptor tyrosine kinases (RTKs) can be regulated by cell adhesion to extracellular matrix (ECM) even in the absence of ligand. We investigated the pathway involved in integrin-mediated RTK activation, using
RON
, the receptor for macrophage-stimulating protein.
Adhesion
of
RON
-expressing epithelial cells to ECM caused phosphorylation of
RON
, which depended on the kinase activity of both
RON
itself and c-Src. This conclusion is based on these observations: 1) ECM-induced
RON
phosphorylation was inhibited in cells expressing kinase-inactive c-Src; 2) active c-Src could phosphorylate immunoprecipitated
RON
from ECM-stimulated cells but not from unstimulated cells; and 3) ECM did not cause
RON
phosphorylation in cells expressing kinase-dead
RON
, nor could active c-Src phosphorylate
RON
immunoprecipitated from these cells. The data fit a pathway in which ECM-induced integrin aggregation causes both c-Src activation and
RON
oligomerization followed by
RON
kinase-dependent autophosphorylation; this results in
RON
becoming a target for activated c-Src, which phosphorylates additional tyrosines on
RON
. Integrin-induced epidermal growth factor receptor (EGFR) phosphorylation also depended on both EGFR and c-Src kinase activities. This sequence appears to be a general pathway for integrin-dependent growth factor RTK activation.
...
PMID:Integrin-mediated RON growth factor receptor phosphorylation requires tyrosine kinase activity of both the receptor and c-Src. 1074 44